The data illustrates the global top 10 biotechnology companies based on market capitalization as of late October, 2017. At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked second among such companies, with a market capitalization of around 96 billion USD. Novo Nordisk also ranks among the top biotech companies by profit.
Global biotechnology Gilead Sciences and Novo Nordisk are two of the biggest biotechnology companies in the world. In June 2015, Gilead Sciences, a company based in the United States, had a market capitalization of nearly 150 billion USD, while Novo Nordisk had market capitalization of 144 billion USD.
Amgen (U.S.) | 129.09 |
Gilead Sciences (U.S.) | 102.96 |
Novo Nordisk (Denmark) | 96.18 |
Celgene (U.S.) | 77.35 |
Biogen (U.S.) | 66.14 |
Allergan (U.S.) | 59.19 |
Teva (Israel) | 48.75 |
CSL (Australia) | 48.3 |
Regeneron (U.S.) | 44.83 |
Shire (Shire) | 42.15 |